PL354623A1 - Sposób wytwarzania koniugatów poliglutaminianu ześrodkiem terapeutycznym - Google Patents

Sposób wytwarzania koniugatów poliglutaminianu ześrodkiem terapeutycznym

Info

Publication number
PL354623A1
PL354623A1 PL00354623A PL35462300A PL354623A1 PL 354623 A1 PL354623 A1 PL 354623A1 PL 00354623 A PL00354623 A PL 00354623A PL 35462300 A PL35462300 A PL 35462300A PL 354623 A1 PL354623 A1 PL 354623A1
Authority
PL
Poland
Prior art keywords
polyglutamate
manufacture
therapeutic agent
agent conjugates
conjugates
Prior art date
Application number
PL00354623A
Other languages
English (en)
Inventor
Anil M. Kumar
Rama Bhatt
J.Peter Klein
Edward Vawter
Original Assignee
Cell Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapeutics, Inc. filed Critical Cell Therapeutics, Inc.
Publication of PL354623A1 publication Critical patent/PL354623A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
PL00354623A 1999-10-12 2000-10-12 Sposób wytwarzania koniugatów poliglutaminianu ześrodkiem terapeutycznym PL354623A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15913599P 1999-10-12 1999-10-12
PCT/US2000/028109 WO2001026693A2 (en) 1999-10-12 2000-10-12 Manufacture of polyglutamate-therapeutic agent conjugates

Publications (1)

Publication Number Publication Date
PL354623A1 true PL354623A1 (pl) 2004-02-09

Family

ID=22571222

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00354623A PL354623A1 (pl) 1999-10-12 2000-10-12 Sposób wytwarzania koniugatów poliglutaminianu ześrodkiem terapeutycznym

Country Status (16)

Country Link
US (2) US20020077279A1 (pl)
EP (2) EP1225917A2 (pl)
JP (1) JP2003511423A (pl)
KR (1) KR100821437B1 (pl)
CN (2) CN101507820A (pl)
AU (1) AU781735B2 (pl)
BR (1) BRPI0014652B1 (pl)
CA (1) CA2387611C (pl)
HU (1) HUP0203123A3 (pl)
MX (1) MXPA02003719A (pl)
NO (1) NO20021701L (pl)
NZ (1) NZ529789A (pl)
PL (1) PL354623A1 (pl)
SG (1) SG147286A1 (pl)
WO (1) WO2001026693A2 (pl)
ZA (1) ZA200202695B (pl)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001266853B2 (en) 2000-06-14 2005-02-17 Medarex, Inc. Prodrug compounds with an oligopeptide having an isoleucine residue
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
US8709998B2 (en) 2003-04-22 2014-04-29 Ipsen Pharma S.A.S. Peptide vectors
FR2855521B1 (fr) * 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
US7259156B2 (en) 2004-05-20 2007-08-21 Kosan Biosciences Incorporated Geldanamycin compounds and method of use
US8614228B2 (en) 2004-08-11 2013-12-24 Arqule, Inc. Quinone prodrug compositions and methods of use
WO2006020719A2 (en) 2004-08-11 2006-02-23 Arqule, Inc. Aminoacid conjugates of beta - lapachone for tumor targeting
CN101023119B (zh) 2004-09-22 2010-05-05 日本化药株式会社 新型嵌段共聚物，胶束制剂以及含胶束制剂为活性组分的抗癌剂
JP5237821B2 (ja) 2005-12-05 2013-07-17 日東電工株式会社 ポリグルタミン酸−アミノ酸結合体および方法
KR20080074202A (ko) * 2005-12-06 2008-08-12 셀 쎄러퓨틱스 인코포레이티드 에스트로겐 암 요법
US7462627B2 (en) * 2006-02-09 2008-12-09 Enzon Pharmaceuticals, Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
US7671067B2 (en) * 2006-02-09 2010-03-02 Enzon Pharmaceuticals, Inc. Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin
KR20080106254A (ko) 2006-03-28 2008-12-04 니폰 가야꾸 가부시끼가이샤 탁산류의 고분자 결합체
CA2652656A1 (en) 2006-05-18 2007-11-29 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of podophyllotoxins
EP2080779B1 (en) 2006-11-06 2016-05-18 Nippon Kayaku Kabushiki Kaisha Polymeric derivative of nucleic acid metabolic antagonist
EP2090607B1 (en) 2006-11-08 2015-05-20 Nippon Kayaku Kabushiki Kaisha Polymeric derivative of nucleic acid metabolic antagonist
CN101209350B (zh) * 2006-12-30 2011-09-07 中国人民解放军军事医学科学院毒物药物研究所 以氨基酸为连接子的多聚谷氨酸-药物偶合物
MX2009008549A (es) * 2007-02-09 2009-08-18 Enzon Pharmaceuticals Inc Tratamiento de canceres resistentes o refractarios con conjugados polimericos de brazos multiples de 7-etil-10-hidroxicamptotecina.
EP2144631A2 (en) * 2007-04-10 2010-01-20 Nitto Denko Corporation Multi-functional polyglutamate drug carriers
BRPI0810717A2 (pt) 2007-04-30 2016-05-24 Arqule Inc sulfonato hidroxi de composto de quinona e seus usos
JP2010528122A (ja) * 2007-05-09 2010-08-19 日東電工株式会社 白金薬剤と結合されたポリマー
EP2155253A2 (en) * 2007-05-09 2010-02-24 Nitto Denko Corporation Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
DK2155255T3 (da) * 2007-05-09 2013-09-02 Nitto Denko Corp Sammensætninger der omfatter en hydrofob forbindelse og et polyaminosyrekonjugat
US8703878B2 (en) 2007-09-28 2014-04-22 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of steroids
KR20100122510A (ko) * 2008-03-06 2010-11-22 닛토덴코 가부시키가이샤 중합체 파클리탁셀 접합체 및 암 치료 방법
KR101589582B1 (ko) 2008-03-18 2016-01-28 니폰 가야꾸 가부시끼가이샤 생리활성물질의 고분자량 결합체
JP5366940B2 (ja) 2008-05-08 2013-12-11 日本化薬株式会社 葉酸若しくは葉酸誘導体の高分子結合体
TW201010732A (en) * 2008-08-29 2010-03-16 Enzon Pharmaceuticals Inc Method of treating RAS associated cancer
WO2010042638A2 (en) * 2008-10-07 2010-04-15 Young Bok Lee Hpma - docetaxel or gemcitabine conjugates and uses therefore
WO2010045370A2 (en) * 2008-10-15 2010-04-22 Nitto Denko Corporation Method of preparing polyglutamate conjugates
US20100098654A1 (en) * 2008-10-21 2010-04-22 Fabio Pastorino Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
DE102008060549A1 (de) * 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
JP5544357B2 (ja) 2009-05-15 2014-07-09 日本化薬株式会社 水酸基を有する生理活性物質の高分子結合体
CN104587484A (zh) 2009-10-13 2015-05-06 瑞沙恩医药公司 用于抗癌剂递送的聚合物系统
AU2011224374A1 (en) * 2010-03-11 2012-09-27 Nitto Denko Corporation Carbohydrate-polyamino acid-drug conjugates
EP4450523A3 (en) 2010-04-02 2025-03-12 Amunix Pharmaceuticals, Inc. Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
JP5856069B2 (ja) 2010-11-17 2016-02-09 日本化薬株式会社 新規なシチジン系代謝拮抗剤の高分子誘導体
CN102649810A (zh) * 2011-05-19 2012-08-29 东北林业大学 喜树碱衍生物、其制备方法和用途
WO2013006173A1 (en) 2011-07-07 2013-01-10 Empire Technology Development Llc Fluorinated block co-polymers
JP5711378B2 (ja) 2011-09-11 2015-04-30 日本化薬株式会社 ブロック共重合体の製造方法
US8383093B1 (en) 2011-11-01 2013-02-26 Serina Therapeutics, Inc. Subcutaneous delivery of poly(oxazoline) conjugates
WO2013151537A1 (en) 2012-04-03 2013-10-10 Empire Technology Development Llc Biocompatible adhesive polymers
CN105143244A (zh) 2013-04-26 2015-12-09 日东电工株式会社 降低多聚阴离子聚合物偶联物中的内毒素
KR101507119B1 (ko) * 2013-05-31 2015-03-30 주식회사 바이오리더스 점막 점착성 폴리감마글루탐산 나노마이셀 및 이를 이용한 약물 전달체
CN106267227A (zh) * 2016-08-12 2017-01-04 北京蓝贝望生物医药科技股份有限公司 抗肿瘤药物
CN106750272B (zh) * 2016-12-05 2019-05-28 福建卫生职业技术学院 一种水溶性蛇葡萄素聚合物
CN110123748A (zh) * 2019-04-22 2019-08-16 南京师范大学 一种叶酸介导的靶向双载药聚合物胶束及其制备方法和应用
CN113773282A (zh) * 2021-09-22 2021-12-10 无锡紫杉药业有限公司 一种10-乙酰紫杉醇的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US5629433A (en) * 1994-07-18 1997-05-13 Hauser, Inc. Selective process for the deacylation and deacetylation of taxol and taxanes
CA2192725C (en) * 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
PL189698B1 (pl) * 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
KR20020082888A (ko) * 2000-03-17 2002-10-31 쎌세러퓨틱스,인코포레이티드 폴리글루탐산-캄프토테신 컨주게이트 및 제조 방법

Also Published As

Publication number Publication date
HUP0203123A3 (en) 2004-12-28
US20020077279A1 (en) 2002-06-20
US20030224971A1 (en) 2003-12-04
CA2387611A1 (en) 2001-04-19
US7399860B2 (en) 2008-07-15
EP1225917A2 (en) 2002-07-31
BR0014652A (pt) 2003-06-10
KR100821437B1 (ko) 2008-04-10
KR20020059616A (ko) 2002-07-13
CN101507820A (zh) 2009-08-19
WO2001026693A2 (en) 2001-04-19
WO2001026693A3 (en) 2001-12-27
CA2387611C (en) 2011-03-29
AU781735B2 (en) 2005-06-09
NO20021701L (no) 2002-05-23
NZ529789A (en) 2005-04-29
AU1079301A (en) 2001-04-23
BRPI0014652B1 (pt) 2016-08-09
SG147286A1 (en) 2008-11-28
EP1466627A1 (en) 2004-10-13
MXPA02003719A (es) 2002-08-30
NO20021701D0 (no) 2002-04-11
JP2003511423A (ja) 2003-03-25
HUP0203123A2 (hu) 2003-01-28
CN1607962A (zh) 2005-04-20
ZA200202695B (en) 2004-02-25

Similar Documents

Publication Publication Date Title
HUP0203123A3 (en) Process for preparation of polyglutamate-therapeutic agent conjugates
TW525477U (en) Compound napkin
EP1166786A4 (en) MEDICAL COMPOSITIONS
GB0018240D0 (en) Polymeric conjugates of antitumor agents
EG22530A (en) Preparation of substituted piperidin-4-ones
PL339848A1 (en) Therapeutic agent against hypephosphataemia
AU1554301A (en) Radioprotecting agent
AP2001002273A0 (en) Rescorcinol composition
EP1218407A4 (en) USES OF KAPPA-CONOTOXIN PVIIA
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
EP1142565A4 (en) AQUEOUS THERAPEUTIC COMPOSITIONS
GB0030067D0 (en) Therapeutic agent
GB0012718D0 (en) Conjugates of aminodrugs
GB2366984B (en) Composition
EP1291461A4 (en) COLOR RECOVERY FUNDS
PL350963A1 (en) Use of arylalkanoylpyridazines
AU2001275696A1 (en) Therapeutic agent
GB9906124D0 (en) Therapeutic agent
GB0029300D0 (en) Composition
GB9921062D0 (en) Use of cholestrol-lowering agent
GB9912039D0 (en) Gene-activating conjugates
GB9925382D0 (en) Preparation of sulphides
TW386360U (en) Improvement of underwear
TW438171U (en) Supporter
TW394123U (en) Structure of emery-roller

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed